Immunic, Inc. (IMUX) earnings
IMUX earnings moved a median of +0.85% by the close. Quarterly and annual IMUX reports and results, each read against the price at its own news timestamp. Back to the IMUX overview →
21 measured IMUX earnings events.
Where these IMUX earnings landedvs 19 measured IMUX earnings reactions
| Middle 50% of IMUX earnings reactions | -5.22% to +8.78% |
|---|---|
| Median reaction (to close) | +0.85% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 IMUX earnings events with a measured close landed between -5.22% and +8.78%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IMMUNIC, INC. For: Jun 30 | SEC filing · Form 10-Q | +2.28% | +8.78% | |
| Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +2.28% | +8.78% | |
| Form 10-Q IMMUNIC, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.26% | +12.51% | |
| Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.26% | +12.51% | |
| Form 10-K/A IMMUNIC, INC. For: Dec 31 | SEC filing · Form 10-K | +0.57% | +3.18% | |
| Form 10-K IMMUNIC, INC. For: Dec 31 | SEC filing · Form 10-K | -2.60% | +2.56% | |
| Form 10-Q IMMUNIC, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.17% | — | |
| Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -1.17% | — | |
| Form 10-Q IMMUNIC, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.10% | -7.46% | |
| Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.10% | -7.46% | |
| Form 10-Q IMMUNIC, INC. For: Mar 31 | SEC filing · Form 10-Q | -2.00% | -3.90% | |
| Form 10-K IMMUNIC, INC. For: Dec 31 | SEC filing · Form 10-K | -4.24% | -7.63% | |
| Form 10-Q IMMUNIC, INC. For: Sep 30 | SEC filing · Form 10-Q | +2.60% | +0.85% | |
| Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +2.60% | +0.85% | |
| Form 10-Q IMMUNIC, INC. For: Jun 30 | SEC filing · Form 10-Q | +5.91% | +21.82% | |
| Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +5.91% | +21.82% | |
| Form 10-Q IMMUNIC, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.75% | -5.22% | |
| Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.75% | -5.22% | |
| Form 10-K IMMUNIC, INC. For: Dec 31 | SEC filing · Form 10-K | -0.39% | -6.15% | |
| Form 10-Q IMMUNIC, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.99% | -1.96% | |
| Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | -0.99% | -1.96% |
Keep exploring
More IMUX: analyst actions → · SEC filings → · IMUX overview →